MAZEMaze Therapeutics, Inc.

$29.59

Is the business good?

How good a business is MAZE?

Share count, year on year
+35%

Share count, year on year · shareholders own a smaller slice than a year ago

Details
Free cash flow, trailing twelve months
−$107M
Net income, trailing twelve months
−$134M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.